MRI biomarkers of post-stroke stem cell implantation and motor recovery: systematic review of clinical trials
Abstract
Background: Stroke causes long-term disability, and stem cell implantation may augment neural repair. Advanced MRI may provide objective biomarkers of tissue remodeling associated with motor recovery.
Methods: Five databases were searched per PRISMA 2020 (PROSPERO CRD420251085067). Clinical trials enrolling stroke patients treated with mesenchymal stem cells (MSCs), mononuclear cells (MNCs), or neural stem cells (NSCs) were included if they reported standardized motor scales and advanced MRI (DTI, fMRI/rs-fMRI, or MRS). Risk of bias was assessed with RoB 2 or ROBINS-I.
Results: Eleven trials (5 randomized, 6 non-randomized) comprising 513 participants were included. DTI was used in 9 studies, fMRI in 4, rs-fMRI in 3, and MRS in 1. MSC trials demonstrated the most consistent associations with motor improvement, though many lacked robust controls and were accompanied by preserved or increased corticospinal tract fractional anisotropy and greater task-related BOLD activity within motor regions (BA4/BA6). MNC trials reported NIHSS reductions and later increases in relative FA; the single MRS study suggested rising N-acetylaspartate with decreasing choline. Evidence for NSCs was limited to one small trial reporting motor gains with increased fractional anisotropy.
Conclusions: Multimodal MRI, especially DTI and fMRI, provides tractable biomarkers for monitoring post-stroke stem cell interventions; current clinical evidence shows associations with motor improvement and MRI…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 513 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.